Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio Growth (3y) (2014 - 2025)
Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.14% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.23% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -28.01% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -32.31% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 26.99% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 41.72% |
| 10 | Supernus Pharmaceuticals | 2.72 Bn | 2.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -26.93% |
| Sep 30, 2025 | -1,436.35% |
| Jun 30, 2025 | 616.38% |
| Mar 31, 2025 | -367.96% |
| Dec 31, 2024 | 72.49% |
| Sep 30, 2024 | 310.89% |
| Jun 30, 2024 | -4.37% |
| Mar 31, 2024 | -33.20% |
| Dec 31, 2023 | -39.34% |
| Mar 31, 2023 | -33.28% |
| Dec 31, 2022 | 14.18% |
| Sep 30, 2022 | -27.06% |
| Jun 30, 2022 | -73.24% |
| Mar 31, 2022 | -79.42% |
| Dec 31, 2021 | -39.25% |
| Sep 30, 2021 | 47.09% |
| Jun 30, 2021 | 13.87% |
| Mar 31, 2021 | -16.61% |
| Sep 30, 2020 | -17.83% |
| Mar 31, 2020 | -26.16% |